Specifically, the tumor cell apoptosis from Eu-FBCP/PTX treatment triggered the expression of HMGB1 and CRT, demonstrating greater DC maturation and activation of antitumor IFN-γ+CD8+ and granzyme B+CD8+ T cells compared with Eu-s/PTX. The gene discussed is HMGB1; the disease is neoplasm.